Assessment of aqueous humor dynamics in the mouse by a novel method of constant-flow infusion

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 685-694

  Cameron Millar, J ^a   Clark, Abbot F ^b,c   Pang, Iok Hou ^a,b,c  

^a ALCON RESEARCH LTD   (United States)

^b North Texas Eye Research Institute   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; BRIMONIDINE; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; LATANOPROST; ANTIHYPERTENSIVE AGENT; COLORING AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; PROSTAGLANDIN F; QUINOXALINE DERIVATIVE;

ADULT ANIMAL; ANALYTIC METHOD; ANIMAL EXPERIMENT; AQUEOUS HUMOR FLOW; ARTICLE; CONSTANT FLOW INFUSION; CONTROLLED STUDY; INTRAOCULAR PRESSURE; MALE; MANOMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TONOMETRY; VENOUS PRESSURE; ANIMAL; AQUEOUS HUMOR; BAGG ALBINO MOUSE; DRUG EFFECT; METABOLISM; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY; SCLERA; TRABECULAR MESHWORK; UVEA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; BETAXOLOL; COLORING AGENTS; DEXTRANS; FLUORESCEIN-5-ISOTHIOCYANATE; INTRAOCULAR PRESSURE; MALE; MANOMETRY; MICE; MICE, INBRED BALB C; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; SCLERA; TONOMETRY, OCULAR; TRABECULAR MESHWORK; UVEA; VENOUS PRESSURE;

EID: 79953286683     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6069     Document Type: Article

References (64)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
2. Zhan GL, Lee PY, Ball DC, et al. Time dependent effects of sympathetic denervation on aqueous humor dynamics and choroidal blood flow in rabbits. Curr Eye Res. 2002;25:99-105.
3. Millar JC, Gabelt BT, Kaufman PL. Aqueous humor dynamics. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia: Lippincott-Williams and Wilkins; 1998:1-34.
4. Millar C, Kaufman PL. Aqueous humor: secretion and dynamics. In: Tasman W, Jaeger EA, eds. Duane's Foundations of Clinical Ophthalmology. Philadelphia: Lippincott-Raven; 1995:1-51.
5. Barany EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol. 1964;3:135-143.
6. Kaufman PL. Some thoughts on the pressure-dependence of uveo-scleral flow. J Glaucoma. 2003;12:89.
7. Tian B, Kaufman PL. Effects of the rho kinase inhibitor Y-27632 and the phosphatase inhibitor calyculin A on outflow facility in monkeys. Exp Eye Res. 2005;80:215-225.
8. Millar JC, Gabelt BT, Hubbard WC, Kiland JA, Kaufman PL. Endo-thelin-1 effects on aqueous humor dynamics in monkeys. Acta Ophthalmol Scand. 1998;76:663-667.
9. Kaufman PL. Non-additivity of maximal pilocarpine and cytocha-lasin effects on outflow facility. Exp Eye Res. 1987;44:283-291.
10. Kaufman PL, Erickson KA. Cytochalasin B and D dose-outflow facility response relationships in the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1982;23:646-650.
11. Kaufman PL, Barany EH. Cytochalasin B reversibly increases outflow facility in the eye of the cynomolgus monkey. Invest Ophthalmol Vis Sci. 1977;16:47-53.
12. Gabelt BT, Millar JC, Kiland JA, Peterson JA, Seeman JL, Kaufman PL. Effects of serotonergic compounds on aqueous humor dynamics in monkeys. Curr Eye Res. 2001;23:120-127.
13. Gabelt BT, Kaufman PL. The effect of prostaglandin F2a on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res. 1990; 51:87-91.
14. Bill A. Effects of Na2EDTA and alpha-chymotrypsin on aqueous humor outflow conductance in monkey eyes. Uppsala J Med Sci. 1980;85:311-319
15. Taniguchi T, Haque MS, Sugiyama K, Hori N, Kitazawa Y. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits. J Ocul Pharmacol Ther. 1996;12:489-498.
16. Roy S, Boldea R, Nguyen C, Perez D, Curchod M, Mermoud A. Analyse de la filtration suivant le type d'implants apres sclerecto-mie profonde chez le lapin. Klin Monatsbl Augenheilkd. 2001; 218:354-359
17. Puras G, Santafe J, Segarra J, Garrido M, Melena J. The effect of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in rabbits with a-chymotrypsin-induced ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 2002; 240:322-328.
18. Poyer JF, Gabelt B, Kaufman PL. The effect of topical prostaglandin F2ce on uveoscleral outflow and outflow facility in the rabbit eye. Exp Eye Res. 1992;54:277-283.
19. Perkins TW, Faha B, Ni M, et al. Adenovirus-mediated gene therapy using human p21 WAF-1/Cip-1 to prevent wound healing in a rabbit model of glaucoma filtration surgery. Arch Ophthalmol. 2002;120:941-949.
20. Melena J, Zalduegui A, Arcocha P, Santafe J, Segarra J. Topical verapamil lowers outflow facility in the rabbit eye. J Ocul Pharmacol Ther. 1999;15:199-205.
21. Inoue T, Yokoyama T, Mori Y, et al. The effect of topical CS-088, an AT-1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits. Curr Eye Res. 2001;23:133-138.
22. Fourman S, Fourman MB. Correlation of tonography and constant pressure perfusion measurements of outflow facility in the rabbit. Curr Eye Res. 1989;8:963-969.
23. Chidlow G, Cupido A, Melena J, Osborne NN. Flesinoxan, a 5-HT1a receptor agonist/alpha-1 adrenoceptor antagonist, lowers intraocular pressure in NZW rabbits. Curr Eye Res. 2001;23:144-153
24. Becker HH, Eisenberg DL, Wang N, Steinert RF, Schuman JS. Radical keratotomy increases outflow facility in the porcine eye in vivo. Curr Eye Res. 1997;16:1193-1197.
25. Mermoud A, Baerveldt G, Minckler DS, Prata JA, Rao NA. Aqueous humor dynamics in rats. Graefes Arch Clin Exp Ophthalmol. 1996;234:S198-S203
26. Kee C, Hong T, Choi K. A sensitive ocular perfusion apparatus measuring outflow facility. Curr Eye Res. 1997;16:1198-1201.
27. Crowston JG, Aihara M, Lindsey JD, Weinreb RN. Effect of latano-prost on outflow facility in the mouse. Invest Ophthalmol Vis Sci. 2004;45:2240-2245.
28. Aihara M, Lindsey JD, Weinreb RN. Aqueous humor dynamics in mice. Invest Ophthalmol Vis Sci. 2003;44:5168-5173
29. Zhang Y, Davidson BR, Stamer WD, Barton JK, Marmorstein LY, Marmorstein AD. Enhanced inflow and outflow rates despite lower IOP in bestrophin-2-deficient mice. Invest Ophthalmol Vis Sci. 2009;50:765-770.
30. Toris CB, Fan S, Johnson TV, Ishimoto B. Aqueous Flow Measured by Fluorophotometry in the Mouse. Association of Ocular and Pharmacology Therapeutics. Abs. 2007;39
31. Avila MY, Mitchell CH, Stone RA, Civan MM. Noninvasive assessment of aqueous humor turnover in the mouse eye. Invest Ophthalmol Vis Sci. 2003;44:722-727.
32. Nilsson SFE, Samuelsson M, Bill A, Stjernschantz J. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2ce-1-isopropyl ester in the cynomolgus monkey. Exp Eye Res. 1989;48:707-716.
33. Gabelt BT, Kaufman PL. Prostaglandin F2ce increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res. 1989;49:389-402.
34. Bill A. Conventional and uveo-scleral drainage of aqueous humor in the cynomolgus monkey (Macaca irus) at normal and high intraocular pressures. Exp Eye Res. 1966;5:45-54.
35. Aihara M, Lindsey JD, Weinreb RN. Episcleral venous pressure of mouse eye and effect of body position. Curr Eye Res. 2003;27: 355-362.
36. Smith RS, Sundberg JP, John SWM. The anterior segment and ocular adnexae. In: Smith RS, John SWM, Nishina PM, Sundberg JP, eds. Systemic Evaluation of the Mouse Eye. Anatomy, Pathology, and Biomethods. Boca Raton, FL: CRC Press; 2002;3-23
37. Smith RSP, Smith RS, John SWM, Nishina PM, Sundberg JP, eds. Systemic Evaluation of the Mouse Eye. Anatomy, Pathology, and Biomethods. Boca Raton, FL: CRC Press; 2002.
38. Wang W-H, Millar JC, Pang I-H, Wax MB, Clark AF. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005;46:4617-4621.
39. Wang R-F, Lee P-Y, Mittag TW, Podos SM, Serle JB. Effect of 5-methylurapidil, an a1a-adrenergic antagonist and 5-hydroxytryp-tamine 1a agonist on aqueous humor dynamics in monkeys and rabbits. Curr Eye Res. 1997;16:769-775
40. Taniguchi T, Okada K, Haque MSR, Sugiyama K, Kitazawa Y. Effects of endothelin-1 on intraocular pressure and aqueous humor dynamics in the rabbit eye. Curr Eye Res. 1994;13:461-464.
41. Burke J, Schwartz M. Preclinical evaluation of brimonidine. Surv Ophthalmol. 1996;41:S9-S18.
42. Maepea O, Bill A. The pressures in the episcleral veins, Schlemm's canal and the trabecular meshwork in monkeys: effects of changes in intraocular pressure. Exp Eye Res. 1989;49:645-663.
43. Pang I-H, Wang W-H, Millar JC, Clark AF. Intraocular pressure measurement in rodents. Chinese J Ophthalmol. 2008;44:465-468.
44. Detweiler DK, Patterson DF, Luginbuhl H, Buchanan JW, Ratcliffe HL. Catcott EJ, ed. Diseases of the Cardiovascular System in Canine Medicine. Santa Barbara CA: American Veterinary Publications, Inc.; 1968;589-679
45. Avila MY, Carre DA, Stone RA, Civan MM. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Invest Ophthalmol Vis Sci. 2001;42:1841-1846.
46. Aihara M, Lindsey JD, Weinreb RN. Reduction of intraocular pressure in mouse eyes treated with latanoprost. Invest Ophthalmol Vis Sci. 2002;43:146-150.
47. Ota T, Murata H, Sugimoto E, Aihara M, Araie M. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation. Invest Ophthalmol Vis Sci. 2005;46:2006-2011.
48. Husain S, Whitlock NA, Rice DS, Crosson CE. Effects of latanoprost on rodent intraocular pressure. Exp Eye Res. 2006;83:1453-1458.
49. Saeki T, Aihara M, Ohashi M, Araie M. The efficacy of TonoLab in detecting physiological and pharmacological changes of mouse intraocular pressure;- comparison with TonoPen and microneedle manometry. Curr Eye Res. 2008;33:247-252.
50. Akaishi T, Odani-Kawabata N, Ishida N, Nakamura M. Ocular hypotensive effects of anti-glaucoma agents in mice. J Ocul Pharmacol Ther. 2009;25:401-408.
51. Whitlock NA, Harrison B, Mixon T, et al. Decreased intraocular pressure in mice following either pharmacological or genetic inhibition of ROCK. J Ocul Pharmacol Ther. 2009;25:187-194.
52. Weinreb RN, Toris C, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47:S53-S64.
53. Toris CB, Camras CB, Yablonski ME. Effects of PhXA41, a new prostaglandin F2a analog, on aqueous humor dynamics in human eyes. Ophthalmology. 1993;100:1297-1304.
54. Brubaker RF. Mechanism of action of bimatoprost (Lumigan). Surv Ophthalmol. 2001;45(suppl 4):S347-S351
55. Toris CB, Zhan GL, Fan S, et al. Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure. J Glaucoma. 2007;16:189-195
56. Toris CB, Zhan GL, Zhao J, Camras CB, Yablonski ME. Potential mechanism for the additivity of pilocarpine and latanoprost. Am J Ophthalmol. 2001;131:722-728.
57. Sponsel WE, Mensah J, Kiel JW, et al. Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye. Am J Ophthal-mol. 2000;130:151-159.
58. Pang I-H, Clark AF. IOP as a target: inflow and outflow pathways. In: Yorio T, Clark AF, Wax MB, eds. Ocular Therapeutics: Eye on New Discoveries. London: Elsevier. (Academic Press); 2008;45-67.
59. Toris CB, Gleason ML, Camras CB, Yablonski ME. Effects of bri-monidine on aqueous humor dynamics in human eyes. Arch Oph-thalmol. 1995;113:1514-1517.
60. Toris CB, Tafoya ME, Camras CB, Yablonski ME. Effects of apra-clonidine on aqueous humor dynamics in human eyes. Ophthalmology. 1995;102:456-461.
61. Kontiola AI, Goldblum D, Mittag T, Danias J. The induction/impact tonometer: a new instrument to measure intraocular pressure in the rat. Exp Eye Res. 2001;73:781-785.
62. Kontiola AI. A new induction-based impact method for measuring intraocular pressure. Acta Ophthalmol Scand. 2000;78:142-145.
63. Kontiola A. A new electromechanical method for measuring intraocular pressure. Doc Ophthalmol. 1996;93:265-276.
64. Danias J, Kontiola AI, Filippopoulos T, Mittag T. Method for the non-invasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci. 2003;44:1138-1141.